Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

Post by akstockon Oct 20, 2018 3:42pm
245 Views
Post# 28841342

Number of IAN shares MPX shareholders will get

Number of IAN shares MPX shareholders will get

I just watched again the Midas Letter interview of Scott Boyes (CEO of MPX) regarding the IAN / MPX merger

Link: https://www.youtube.com/watch?v=yWWWJMgupRg

Excuse me if it was mentioned somewhere else, but something completely new caught my ears.

At 53:00, James West asked Scott how many shares will MPX end up holding of iAnthus.

Scott mentions the ratio but then conclude by saying "the number of shares will depend on the share price of iAnthus at time of close"

What I conclude from that is they will adjust the # of IAN shares MPX holders will receive to respect the 30.6% premium announced. This way, it protects both companies in the case IAN share price at time of closing would be too low (making MPX sell their company at a lower price) or too high (making IAN buy MPX at an higher price).

Let me know what you think. Before seeing that, I always felt something was wrong about that deal due to the fact that the SP can fluctuate so much by January 2019.

Please correct me if I am wrong and let me know what you think of this and what should be the best strategy to play until the deal closes.

<< Previous
Bullboard Posts
Next >>